Low levels of AMPK promote epithelial‐mesenchymal transition in lung cancer primarily through HDAC4‐ and HDAC5‐mediated metabolic reprogramming
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Low levels of AMPK promote epithelial‐mesenchymal transition in lung cancer primarily through HDAC4‐ and HDAC5‐mediated metabolic reprogramming
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Volume 24, Issue 14, Pages 7789-7801
Publisher
Wiley
Online
2020-06-10
DOI
10.1111/jcmm.15410
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PD‐1 inhibitors for non‐small cell lung cancer patients with special issues: Real‐world evidence
- (2020) Seonggyu Byeon et al. Cancer Medicine
- Epithelial Mesenchymal and Endothelial Mesenchymal Transitions in Hepatocellular Carcinoma: A Review
- (2019) Simona Gurzu et al. Biomed Research International
- HGF/MET Regulated Epithelial-Mesenchymal Transitions And Metastasis By FOSL2 In Non-Small Cell Lung Cancer
- (2019) Jun Yin et al. OncoTargets and Therapy
- Contribution of epithelial-mesenchymal transitions to organogenesis and cancer metastasis
- (2018) Kyra Campbell CURRENT OPINION IN CELL BIOLOGY
- A decrease of ATP production steered by PEDF in cardiomyocytes with oxygen-glucose deprivation is associated with an AMPK-dependent degradation pathway
- (2018) Fan Qiu et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- AMP-activated protein kinase promotes epithelial-mesenchymal transition in cancer cells by Twist1 upregulation
- (2018) Meera Saxena et al. JOURNAL OF CELL SCIENCE
- Tumour biology of obesity-related cancers: understanding the molecular concept for better diagnosis and treatment
- (2016) Seong Lin Teoh et al. TUMOR BIOLOGY
- AMPK-HDAC5 pathway facilitates nuclear accumulation of HIF-1α and functional activation of HIF-1 by deacetylating Hsp70 in the cytosol
- (2015) Shuyang Chen et al. CELL CYCLE
- Impact of Brachyury on epithelial-mesenchymal transitions and chemosensitivity in non-small cell lung cancer
- (2015) KE XU et al. Molecular Medicine Reports
- Metabolic pathways promoting cancer cell survival and growth
- (2015) Lindsey K. Boroughs et al. NATURE CELL BIOLOGY
- AMPK Reverses the Mesenchymal Phenotype of Cancer Cells by Targeting the Akt–MDM2–Foxo3a Signaling Axis
- (2014) Chih-Chien Chou et al. CANCER RESEARCH
- Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth: Connecting TGF-β signaling with “Warburg-like” cancer metabolism and L-lactate production
- (2012) Carmela Guido et al. CELL CYCLE
- AMPK Is a Negative Regulator of the Warburg Effect and Suppresses Tumor Growth In Vivo
- (2012) Brandon Faubert et al. Cell Metabolism
- Understanding the metabolic basis of drug resistance
- (2011) Ubaldo E. Martinez-Outschoorn et al. CELL CYCLE
- Epithelial-Mesenchymal Transitions in Development and Disease
- (2009) Jean Paul Thiery et al. CELL
- Multitargeted Inhibitors in Lung Cancer: New Clinical Data
- (2008) Jair Bar et al. Clinical Lung Cancer
- AMP-Activated Protein Kinase Regulates GLUT4 Transcription by Phosphorylating Histone Deacetylase 5
- (2008) S. L. McGee et al. DIABETES
- AMPK: a key regulator of energy balance in the single cell and the whole organism
- (2008) D G Hardie INTERNATIONAL JOURNAL OF OBESITY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now